Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gastric Cancer

Free Subscription Articles published in Int J Cancer Retrieve available abstracts of 48 articles: HTML format Text format

Single Articles

June 2018
1. NDEGWA N, Ploner A, Liu Z, Roosaar A, et al
   Association between poor oral health and gastric cancer: A prospective cohort study.
   Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31614.
   PubMed     Text format     Abstract available
   
   
   May 2018
2. MIZUGUCHI A, Takai A, Shimizu T, Matsumoto T, et al
   Genetic features of multicentric/multifocal intramucosal gastric carcinoma.
   Int J Cancer. 2018 May 1. doi: 10.1002/ijc.31578.
   PubMed     Text format     Abstract available
   
   
   April 2018
3. SHAO L, Li P, Ye J, Chen J, et al
   Risk of gastric cancer among patients with gastric intestinal metaplasia.
   Int J Cancer. 2018 Apr 29. doi: 10.1002/ijc.31571.
   PubMed     Text format     Abstract available
   
   
   March 2018
4. KIYOZUMI Y, Iwatsuki M, Kurashige J, Ogata Y, et al
   PLOD2 as a potential regulator of peritoneal dissemination in gastric cancer.
   Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31410.
   PubMed     Text format     Abstract available
   
   
   
5. KIM H, Keum N, Giovannucci EL, Fuchs CS, et al
   Garlic intake and gastric cancer risk: results from two large prospective US cohort studies.
   Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31396.
   PubMed     Text format     Abstract available
   
   
   February 2018
6. KIM HJ, Kang SK, Kwon WS, Kim TS, et al
   Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
   Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31304.
   PubMed     Text format     Abstract available
   
   
   
7. HILL DG, Yu L, Gao H, Balic JJ, et al
   Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
   Int J Cancer. 2018 Feb 8. doi: 10.1002/ijc.31298.
   PubMed     Text format     Abstract available
   
   
   December 2017
8. WANG W, Li Z, Wang J, Du M, et al
   A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer.
   Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31197.
   PubMed     Text format     Abstract available
   
   
   October 2017
9. RHYU MG, Oh JH, Hong SJ
   Species-specific role of gene-adjacent retroelements in human and mouse gastric carcinogenesis.
   Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31120.
   PubMed     Text format     Abstract available
   
   
   
10. LUO G, Zhang Y, Guo P, Wang L, et al
    Global patterns and trends in stomach cancer incidence: Age, period and birth cohort analysis.
    Int J Cancer. 2017;141:1333-1344.
    PubMed     Text format     Abstract available
    
    
    July 2017
11. LIU X, Zhang X, Zhang Z, Chang J, et al
    Plasma MicroRNA-based Signatures to Predict 3-year Postoperative Recurrence Risk for Stage II and III Gastric Cancer.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30895.
    PubMed     Text format     Abstract available
    
    
    
12. ROTA M, Pelucchi C, Bertuccio P, Matsuo K, et al
    Alcohol consumption and gastric cancer risk - A pooled analysis within the StoP Project Consortium.
    Int J Cancer. 2017 Jul 18. doi: 10.1002/ijc.30891.
    PubMed     Text format     Abstract available
    
    
    
13. TAKEGAWA N, Nonagase Y, Yonesaka K, Sakai K, et al
    DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30870.
    PubMed     Text format     Abstract available
    
    
    
14. YU G, Hu N, Wang L, Wang C, et al
    Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China.
    Int J Cancer. 2017;141:45-51.
    PubMed     Text format     Abstract available
    
    
    June 2017
15. KORSAK B, Almeida GM, Rocha S, Pereira C, et al
    Porphyrin Modified Trastuzumab Improves Efficacy of HER2 Targeted Photodynamic Therapy of Gastric Cancer.
    Int J Cancer. 2017 Jun 22. doi: 10.1002/ijc.30844.
    PubMed     Text format     Abstract available
    
    
    May 2017
16. MIRANTI EH, Stolzenberg-Solomon R, Weinstein SJ, Selhub J, et al
    Low Vitamin B12 Increases Risk of Gastric Cancer: A Prospective Study of One-Carbon Metabolism Nutrients and Risk of Upper Gastrointestinal Tract Cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30809.
    PubMed     Text format     Abstract available
    
    
    
17. WANG X, Zhou Q, Yu Z, Wu X, et al
    Cancer-associated Fibroblast-derived Lumican Promotes Gastric Cancer Progression via the integrin beta1-FAK signaling pathway.
    Int J Cancer. 2017 May 23. doi: 10.1002/ijc.30801.
    PubMed     Text format     Abstract available
    
    
    
18. JAKSZYN P, Fonseca-Nunes A, Lujan-Barroso L, Aranda N, et al
    Hepcidin levels and gastric cancer risk in the EPIC-EurGast Study.
    Int J Cancer. 2017 May 22. doi: 10.1002/ijc.30797.
    PubMed     Text format     Abstract available
    
    
    April 2017
19. BUSBY J, Murchie P, Murray L, Iversen L, et al
    The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.
    Int J Cancer. 2017;140:1828-1835.
    PubMed     Text format     Abstract available
    
    
    February 2017
20. RONCHETTI L, Melucci E, De Nicola F, Goeman F, et al
    DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30668.
    PubMed     Text format     Abstract available
    
    
    
21. MUHAMMAD JS, Nanjo S, Ando T, Yamashita S, et al
    Autophagy Impairment by Helicobacter pylori-induced Methylation Silencing of MAP1LC3Av1 Promotes Gastric Carcinogenesis.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30657.
    PubMed     Text format     Abstract available
    
    
    December 2016
22. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available
    
    
    
23. PIETRANTONIO F, Caporale M, Morano F, Scartozzi M, et al
    HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
    Int J Cancer. 2016;139:2859-2864.
    PubMed     Text format     Abstract available
    
    
    October 2016
24. WANG T, Cai H, Sasazuki S, Tsugane S, et al
    Fruit and Vegetable Consumption, Helicobacter pylori Antibodies, and Gastric Cancer Risk: A Pooled Analysis of Prospective Studies in China, Japan and Korea.
    Int J Cancer. 2016 Oct 19. doi: 10.1002/ijc.30477.
    PubMed     Text format     Abstract available
    
    
    
25. NAGASE H, Takeoka T, Urakawa S, Morimoto-Okazawa A, et al
    ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori.
    Int J Cancer. 2016 Oct 18. doi: 10.1002/ijc.30475.
    PubMed     Text format     Abstract available
    
    
    August 2016
26. XIA J, Huang N, Huang H, Sun L, et al
    Voltage-gated sodium channel Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1.
    Int J Cancer. 2016 Aug 16. doi: 10.1002/ijc.30381.
    PubMed     Text format     Abstract available
    
    
    
27. NISHIKAWA K, Takahashi T, Takaishi H, Miki A, et al
    Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naive patients with HER2-positive, previously treated, advanced or recurrent gastric cancer (JFMC45-1102).
    Int J Cancer. 2016 Aug 13. doi: 10.1002/ijc.30383.
    PubMed     Text format     Abstract available
    
    
    July 2016
28. KANDA M, Tanaka C, Kobayashi D, Tanaka H, et al
    Epigenetic suppression of the immunoregulator MZB1 is associated with the malignant phenotype of gastric cancer.
    Int J Cancer. 2016 Jul 26. doi: 10.1002/ijc.30286.
    PubMed     Text format     Abstract available
    
    
    April 2016
29. IGUCHI M, Kato J, Fukatsu K, Yamamoto Y, et al
    Serum pepsinogen levels can quantify the risk of development of metachronous gastric cancer after endoscopic resection.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30145.
    PubMed     Text format     Abstract available
    
    
    
30. HIDAKA A, Sasazuki S, Matsuo K, Ito H, et al
    CYP1A1, GSTM1, and GSTT1 genetic polymorphisms and gastric cancer risk among Japanese: A nested case-control study within a large-scale population-based prospective study.
    Int J Cancer. 2016 Apr 7. doi: 10.1002/ijc.30130.
    PubMed     Text format     Abstract available
    
    
    March 2016
31. LIERSCH-LOHN B, Slavova N, Buhr HJ, Bennani-Baiti IM, et al
    Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers.
    Int J Cancer. 2016;138:1220-31.
    PubMed     Text format     Abstract available
    
    
    February 2016
32. WANG Z, Butler LM, Wu AH, Koh WP, et al
    Reproductive factors, hormone use and gastric cancer risk: The Singapore Chinese Health Study.
    Int J Cancer. 2016 Feb 2. doi: 10.1002/ijc.30024.
    PubMed     Text format     Abstract available
    
    
    January 2016
33. FANG WL, Lan YT, Huang KH, Liu CA, et al
    Clinical significance of circulating plasma DNA in gastric cancer.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30018.
    PubMed     Text format     Abstract available
    
    
    
34. HUI KF, Cheung AK, Choi CK, Yeung PL, et al
    Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Int J Cancer. 2016;138:125-36.
    PubMed     Text format     Abstract available
    
    
    November 2015
35. SUGIMOTO R, Sugai T, Habano W, Endoh M, et al
    Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
    Int J Cancer. 2015 Nov 4. doi: 10.1002/ijc.29916.
    PubMed     Text format     Abstract available
    
    
    October 2015
36. DONG W, Qin G, Shen R
    Rab11-FIP2 promotes the metastasis of gastric cancer cells.
    Int J Cancer. 2015 Oct 26. doi: 10.1002/ijc.29899.
    PubMed     Text format     Abstract available
    
    
    
37. MURPHY G, Freedman ND, Michel A, Fan JH, et al
    Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Int J Cancer. 2015;137:1938-46.
    PubMed     Text format     Abstract available
    
    
    September 2015
38. IZUMI D, Ishimoto T, Miyake K, Sugihara H, et al
    CXCL12/CXCR4 Activation by Cancer-Associated Fibroblasts Promotes Integrin ss1 Clustering and Invasiveness in Gastric Cancer.
    Int J Cancer. 2015 Sep 28. doi: 10.1002/ijc.29864.
    PubMed     Text format     Abstract available
    
    
    August 2015
39. WADA K, Tsuji M, Tamura T, Konishi K, et al
    Soy isoflavone intake and stomach cancer risk in Japan: From the Takayama study.
    Int J Cancer. 2015;137:885-92.
    PubMed     Text format     Abstract available
    
    
    
40. KANDA M, Shimizu D, Fujii T, Sueoka S, et al
    Function and diagnostic value of Anosmin-1 in gastric cancer progression.
    Int J Cancer. 2015 Aug 13. doi: 10.1002/ijc.29803.
    PubMed     Text format     Abstract available
    
    
    
41. STEFFEN A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, et al
    General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2015;137:646-57.
    PubMed     Text format     Abstract available
    
    
    
42. BUCKLAND G, Travier N, Huerta JM, Bueno-de-Mesquita HB, et al
    Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study.
    Int J Cancer. 2015;137:598-606.
    PubMed     Text format     Abstract available
    
    
    
43. SCHULZ C, Kullmann F, Kunzmann V, Fuchs M, et al
    NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
    Int J Cancer. 2015;137:678-85.
    PubMed     Text format     Abstract available
    
    
    July 2015
44. CHARVAT H, Sasazuki S, Inoue M, Iwasaki M, et al
    Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC Study Cohort II.
    Int J Cancer. 2015 Jul 28. doi: 10.1002/ijc.29705.
    PubMed     Text format     Abstract available
    
    
    
45. CAMARGO MC, Beltran M, Conde-Glez CJ, Harris PR, et al
    Serological response to Helicobacter pylori infection among Latin American populations with contrasting risks of gastric cancer.
    Int J Cancer. 2015 Jul 14. doi: 10.1002/ijc.29678.
    PubMed     Text format     Abstract available
    
    
    
46. FONSECA-NUNES A, Agudo A, Aranda N, Arija V, et al
    Body iron status and gastric cancer risk in the EURGAST study.
    Int J Cancer. 2015 Jul 1. doi: 10.1002/ijc.29669.
    PubMed     Text format     Abstract available
    
    
    June 2015
47. GUO Y, Zhou J, Huang A, Li J, et al
    Spatially defined microsatellite analysis reveals extensive genetic mosaicism and clonal complexity in intestinal metaplastic glands.
    Int J Cancer. 2015;136:2973-9.
    PubMed     Text format     Abstract available
    
    
    
48. ISHIMOTO T, Baba H, Izumi D, Sugihara H, et al
    Current perspectives towards the identification of key players in gastric cancer microRNA dysregulation.
    Int J Cancer. 2015 Jun 4. doi: 10.1002/ijc.29627.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: